Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination

Link to article at PubMed

Cleve Clin J Med. 2021 May 6. doi: 10.3949/ccjm.88a.ccc078. Online ahead of print.


Vaccine-induced thrombotic thrombocytopenia (VITT) has been reported after vaccination with the AztraZeneca ChAdOx1 nCoV-19 and the Johnson and Johnson Ad26. COV2.S vaccines. This manuscript provides a brief overview of reported cases, clinical and laboratory features, and current understanding of the pathogenesis of VITT. The author also poses unananswered questions and identifies directions for future study.

PMID:33958344 | DOI:10.3949/ccjm.88a.ccc078

Leave a Reply

Your email address will not be published. Required fields are marked *